Serving leading biopharmaceutical companies globally:

Last Updated: February 28, 2020

DrugPatentWatch Database Preview

Patent: 10,005,783

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,005,783

Title:	Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
Abstract:	Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal.
Inventor(s):	Haas; Julia (Boulder, CO), Andrews; Steven W. (Boulder, CO), Jiang; Yutong (Boulder, CO), Zhang; Gan (Boulder, CO)
Assignee:	Array BioPharma Inc. (Boulder, CO)
Application Number:	15/399,389
Patent Claims:	see list of patent claims

Details for Patent 10,005,783

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Genentech	RITUXAN	rituximab	SOLUTION;INTRAVENOUS	103705	001	1997-11-26	Start Trial	Array BioPharma Inc. (Boulder, CO)	2028-10-22	RX		search
Genentech	RITUXAN	rituximab	SOLUTION;INTRAVENOUS	103705	002	1997-11-26	Start Trial	Array BioPharma Inc. (Boulder, CO)	2028-10-22	RX		search
Genentech	HERCEPTIN	trastuzumab	VIAL; INTRAVENOUS	103792	001	1998-09-25	Start Trial	Array BioPharma Inc. (Boulder, CO)	2028-10-22	RX	Orphan	search
Genentech	PERJETA	pertuzumab	VIAL; SINGLE-USE	125409	001	2012-06-08	Start Trial	Array BioPharma Inc. (Boulder, CO)	2028-10-22	RX		search
Genentech	KADCYLA	ado-trastuzumab emtansine	VIAL; SINGLE-USE	125427	001	2013-02-22	Start Trial	Array BioPharma Inc. (Boulder, CO)	2028-10-22	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 10,005,783

Subscribe to access the full database, or Start Trial
Country	Patent Number	Publication Date
Argentina	074052	Dec 22, 2010
Argentina	112833	Dec 18, 2019
Australia	2009308465	Apr 29, 2010
Australia	2009308465	Feb 12, 2015
Australia	2015200511	Aug 31, 2017
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Harvard Business School

Boehringer Ingelheim

Johnson and Johnson

Moodys

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.